Kenneth Hoberman
Overview
Kenneth Hoberman received an average of $2M in total compensation, including $416K in salary, at Stemline Therapeutics from 2012 to 2019.
2019Stemline TherapeuticsChief Operating Officer
2018Stemline TherapeuticsChief Operating Officer
2017Stemline TherapeuticsChief Operating Officer
2016Stemline TherapeuticsChief Operating Officer
2015Stemline TherapeuticsChief Operating Officer
2014Stemline TherapeuticsChief Operating Officer
2013Stemline TherapeuticsChief Operating Officer
2012Stemline TherapeuticsChief Operating Officer
Source: SEC filings on April 29, 2020, April 30, 2019, April 30, 2018, May 1, 2017, April 8, 2016, and April 30, 2015.
Related executives
We found six more executives who work or worked at Stemline Therapeutics.
Ivan Bergstein
Stemline Therapeutics
Chief Executive Officer
Robert Francomano
Stemline Therapeutics
Chief Commercial Officer
David Gionco
Stemline Therapeutics
Chief Accounting Officer
Eric Rowinsky
Stemline Therapeutics
Chief Medical Officer
Stephen Hall
Stemline Therapeutics
Chief Accounting Officer
John Cavan
Stemline Therapeutics